Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -550 | -971 | -1,188 | -510 | -367 |
| Depreciation Amortization | N/A | 108 | 115 | 80 | 47 |
| Other Working Capital | N/A | 97 | 534 | N/A | N/A |
| Other Operating Activity | 20 | 160 | 0 | 0 | 0 |
| Operating Cash Flow | $-530 | $-606 | $-539 | $-430 | $-320 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -43 | -62 | N/A | N/A |
| Other Investing Activity | 770 | 588 | -464 | -493 | 209 |
| Investing Cash Flow | $770 | $545 | $-525 | $-493 | $209 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 30 | -48 | 118 | 301 | 14 |
| Financing Cash Flow | $30 | $-48 | $118 | $301 | $14 |
| Beginning Cash Position | 620 | 731 | 4,625 | 561 | 93 |
| End Cash Position | 890 | 622 | 3,679 | 4,010 | -171 |
| Net Cash Flow | $270 | $-110 | $-946 | $68 | $-97 |
| Free Cash Flow | |||||
| Operating Cash Flow | -530 | -606 | -539 | -430 | -320 |
| Free Cash Flow | -530 | -606 | -539 | -430 | -320 |